Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH): A Randomized Controlled Trial [EVER Study]
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2018
Price : $35 *
At a glance
- Drugs Conjugated estrogens (Primary)
- Indications Haematuria
- Focus Therapeutic Use
- Acronyms EVER study
- 15 Mar 2016 Planned End Date changed from 1 Oct 2015 to 1 Dec 2017 as per ClinicalTrials.gov record.
- 15 Mar 2016 Planned primary completion date changed from 1 Sep 2015 to 1 Sep 2017 as per ClinicalTrials.gov record.
- 13 Aug 2014 New trial record